Enanta Pharmaceuticals, Inc. (ENTA) Profit Margins
Over the twelve months to 2026-06-30, Enanta Pharmaceuticals, Inc. (ENTA) had operating margin -90.0%, net margin -96.9%, free cash flow margin -56.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ENTAEnanta Pharmaceuticals, Inc.Follow ENTA — free
—
Price chart with a free account
- Market cap
- 339.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 22 days
| Line | FY2013 Sep 13 | FY2014 Sep 14 | FY2015 Sep 15 | FY2016 Sep 16 | FY2017 Sep 17 | FY2018 Sep 18 | FY2019 Sep 19 | FY2020 Sep 20 | FY2021 Sep 21 | FY2022 Sep 22 | FY2023 Sep 23 | FY2024 Sep 24 | FY2025 Sep 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 28.2% | 39.8% | 77.2% | 34.9% | 23.9% | 42.7% | 17.9% | -34.0% | -112.9% | -143.7% | -173.2% | -179.9% | -130.7% | -90.0% | |
| Net margin | 30.0% | 72.1% | 49.1% | 24.5% | 17.2% | 34.8% | 22.6% | -29.5% | -81.4% | -141.3% | -169.0% | -171.6% | -125.4% | -96.9% | |
| FCF margin | 31.3% | 40.1% | 46.2% | 35.2% | 48.8% | 12.7% | 32.2% | 4.6% | -72.9% | -100.9% | -141.7% | -143.0% | -49.2% | -56.6% |
USD millions · SEC XBRL
Enanta Pharmaceuticals, Inc. — questions
- What is Enanta Pharmaceuticals, Inc.'s operating margin?
- -90.0% over the twelve months to 2026-06-30.
- What is Enanta Pharmaceuticals, Inc.'s net profit margin?
- -96.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Enanta Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.